KHTRF - Knight Therapeutics GAAP EPS of -C$0.16 revenue of C$63.81M May, 12 2022 08:12 AM Knight Therapeutics Inc Knight Therapeutics press release (OTC:KHTRF): Q1 GAAP EPS of -C$0.16. Revenue of C$63.81M (+38.5% Y/Y). For further details see: Knight Therapeutics GAAP EPS of -C$0.16, revenue of C$63.81M